JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB243230

Anti-BST2/Tetherin antibody [EPR20202-150]

  • RabMAb
  • Recombinant
  • KO Validated
  • 20ul selling size
  • What is this?

Be the first to review this product! Submit a review

|

(10 Publications)

Rabbit Recombinant Monoclonal BST2/Tetherin antibody. Suitable for IP, Flow Cyt, WB, ICC/IF and reacts with Human samples. Cited in 10 publications.

View Alternative Names

CD317, Bone marrow stromal antigen 2, BST-2, HM1.24 antigen, Tetherin, BST2

7 Images
Immunocytochemistry/ Immunofluorescence - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (human epithelial cell line from cervix adenocarcinoma) cells labeling BST2/Tetherin with ab243230 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody (Green). Confocal image showing cytoplasmic staining in HeLa cells (PMID : 20529266).

The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) (red) at 1/200 dilution.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.

Immunocytochemistry/ Immunofluorescence - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized U-937 (human histiocytic lymphoma cell line) cells labeling BST2/Tetherin with ab243230 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody (Green). Confocal image showing cytoplasmic staining in U-937 cells (PMID : 20529266).

The nuclear counter stain is DAPI (blue). Tubulin is detected with Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) (red) at 1/200 dilution.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution.

Flow Cytometry - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)

Flow cytometric analysis of HeLa (human epithelial cell line from cervix adenocarcinoma) cell line labeling BST2/Tetherin with ab243230 at 1/700 dilution (Red) compared with a Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730) (black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody) (blue). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077) at 1/2000 dilution was used as the secondary antibody. Gated on viable cells.

Immunoprecipitation - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)
  • IP

Unknown

Immunoprecipitation - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)

BST2/Tetherin was immunoprecipitated from 0.35 mg HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate with ab243230 at 1/40 dilution. Western blot was perfromed on the immunoprecipitate using ab243230 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used afor detection at 1/5000 dilution.

Lane 1 : HeLa whole cell lysate 10 μg (input)
Lane 2 : ab243230 IP in HeLa whole cell lysate.
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab243230 in HeLa whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST
Exposure time : 3 seconds.

All lanes:

Immunoprecipitation - Anti-BST2/Tetherin antibody [EPR20202-150] (ab243230)

Predicted band size: 20 kDa

false

Western blot - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)
  • WB

Lab

Western blot - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)

Lanes 1 - 4 : Merged signal (red and green). Green - ab243230 observed at 30 kDa. Red - loading control ab7291 (Mouse anti-Alpha Tubulin [DM1A]) observed at 55 kDa.

ab243230 was shown to react with BST2/Tetherin in wild-type HeLa cells in Western blot with loss of signal observed in BST2 knockout samples. Wild-type HeLa and BST2 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab243230 and ab7291 (Mouse anti-Alpha Tubulin [DM1A]) overnight at 4 °C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-BST2/Tetherin antibody [EPR20202-150] (ab243230) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

Bst2 knockout HeLa cell lysate at 20 µg

Lane 3:

Wild-type A431 cell lysate at 20 µg

Lane 4:

BST2 knockout A431 cell lysate at 20 µg

Predicted band size: 20 kDa

Observed band size: 30 kDa

false

Western blot - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)
  • WB

Unknown

Western blot - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)

Blocking/Diluting buffer and concentration : 5% NFDM/TBST

The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 19196977; PMID : 19737401).

BST2/Tetherin is a glycosylated protein, its calculated MW is 20 kDa, and the observed MW is 35 kDa, which is consistent with the literature.

Both 35 and 70 kDa bands were detected under the reducing condition, whereas under the non-reducing condition, only the 70 kDa band was detected.

All lanes:

Western blot - Anti-BST2/Tetherin antibody [EPR20202-150] (ab243230) at 1/1000 dilution

Lane 1:

HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate in the loading buffer containing DTT at 20 µg

Lane 2:

HeLa whole cell lysate in the loading buffer without DTT at 20 µg

Lane 3:

K562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate in the loading buffer containing at 20 µg

Lane 4:

K562 whole cell lysate in the loading buffer without DTT at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 20 kDa

Observed band size: 35 kDa,70 kDa

false

Exposure time: 48s

Western blot - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)
  • WB

Unknown

Western blot - Anti-BST2/Tetherin antibody [EPR20202-150] (AB243230)

Blocking/Diluting buffer and concentration : 5% NFDM/TBST

All lanes:

Western blot - Anti-BST2/Tetherin antibody [EPR20202-150] (ab243230) at 1/1000 dilution

All lanes:

U-937 (human histiocytic lymphoma cell line) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 20 kDa

false

Exposure time: 125s

  • Carrier free

    Anti-BST2/Tetherin antibody [EPR20202-150] - BSA and Azide free (Capture)

  • Carrier free

    Anti-BST2/Tetherin antibody [EPR20202-150] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR20202-150

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, Flow Cyt, ICC/IF, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/40", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/700", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Conditional Ambient
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

IFN-induced antiviral host restriction factor which efficiently blocks the release of diverse mammalian enveloped viruses by directly tethering nascent virions to the membranes of infected cells. Acts as a direct physical tether, holding virions to the cell membrane and linking virions to each other. The tethered virions can be internalized by endocytosis and subsequently degraded or they can remain on the cell surface. In either case, their spread as cell-free virions is restricted (PubMed : 18200009, PubMed : 18342597, PubMed : 19036818, PubMed : 19879838, PubMed : 20019814, PubMed : 20399176, PubMed : 20419159, PubMed : 20940320, PubMed : 21529378, PubMed : 22520941). Its target viruses belong to diverse families, including retroviridae : human immunodeficiency virus type 1 (HIV-1), human immunodeficiency virus type 2 (HIV-2), simian immunodeficiency viruses (SIVs), equine infectious anemia virus (EIAV), feline immunodeficiency virus (FIV), prototype foamy virus (PFV), Mason-Pfizer monkey virus (MPMV), human T-cell leukemia virus type 1 (HTLV-1), Rous sarcoma virus (RSV) and murine leukemia virus (MLV), flavivirideae : hepatitis C virus (HCV), filoviridae : ebola virus (EBOV) and marburg virus (MARV), arenaviridae : lassa virus (LASV) and machupo virus (MACV), herpesviridae : kaposis sarcoma-associated herpesvirus (KSHV), rhabdoviridae : vesicular stomatitis virus (VSV), orthomyxoviridae : influenza A virus, paramyxoviridae : nipah virus, and coronaviridae : SARS-CoV (PubMed : 18200009, PubMed : 18342597, PubMed : 19179289, PubMed : 19879838, PubMed : 20399176, PubMed : 20419159, PubMed : 20686043, PubMed : 20943977, PubMed : 21529378, PubMed : 21621240, PubMed : 22520941, PubMed : 26378163, PubMed : 31199522). Can inhibit cell surface proteolytic activity of MMP14 causing decreased activation of MMP15 which results in inhibition of cell growth and migration (PubMed : 22065321). Can stimulate signaling by LILRA4/ILT7 and consequently provide negative feedback to the production of IFN by plasmacytoid dendritic cells in response to viral infection (PubMed : 19564354, PubMed : 26172439). Plays a role in the organization of the subapical actin cytoskeleton in polarized epithelial cells. Isoform 1 and isoform 2 are both effective viral restriction factors but have differing antiviral and signaling activities (PubMed : 23028328, PubMed : 26172439). Isoform 2 is resistant to HIV-1 Vpu-mediated degradation and restricts HIV-1 viral budding in the presence of Vpu (PubMed : 23028328, PubMed : 26172439). Isoform 1 acts as an activator of NF-kappa-B and this activity is inhibited by isoform 2 (PubMed : 23028328).
See full target information BST2

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Journal of extracellular vesicles 14:e70122 PubMed40704538

2025

Tethered Exosomes Containing the Matrix Metalloproteinase MT1-MMP Contribute to Extracellular Matrix Degradation.

Applications

Unspecified application

Species

Unspecified reactive species

Roberta Palmulli,Hannah K Jackson,James R Edgar

Infectious agents and cancer 20:36 PubMed40514669

2025

DNA hypomethylation modification promotes BST2 expression in cervical cancer by facilitating STAT1 binding to the promoter of BST2.

Applications

Unspecified application

Species

Unspecified reactive species

Reziwanguli Wubuli,Zumurelaiti Ainiwaer,Mayinuer Niyazi,Lili Han

Genome medicine 16:148 PubMed39696540

2024

Spatial transcriptome profiling identifies DTX3L and BST2 as key biomarkers in esophageal squamous cell carcinoma tumorigenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Rutao Li,Na Li,Qianqian Yang,Xing Tong,Wei Wang,Chang Li,Jun Zhao,Dong Jiang,Haitao Huang,Chen Fang,Kai Xie,Jiamin Yuan,Shaomu Chen,Guangbin Li,Haitao Luo,Zhibo Gao,Dongfang Wu,Xiaoli Cui,Wei Jiang,Lingchuan Guo,Haitao Ma,Yu Feng

Cancer gene therapy 32:38-50 PubMed39558134

2024

Serum small extracellular vesicles-derived BST2 as a biomarker for papillary thyroid microcarcinoma promotes lymph node metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Zhen Cao,Yuanyang Wang,Jianqiang Wu,Xiaoyue Tang,Zhihong Qian,Zejian Zhang,Rui Liu,Peng Liu,Zepeng Li,Xiequn Xu,Ziwen Liu

Memorias do Instituto Oswaldo Cruz 119:e240102 PubMed39476027

2024

HSV1-induced enhancement of productive HIV-1 replication is associated with interferon pathway downregulation in human macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Viviane M Andrade,Filipe Pereira-Dutra,Juliana L Abrantes,Milene D Miranda,Thiago Moreno L Souza

EMBO reports 24:e57224 PubMed37818801

2023

Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus release.

Applications

Unspecified application

Species

Unspecified reactive species

Hazel Stewart,Roberta Palmulli,Kristoffer H Johansen,Naomi McGovern,Ola M Shehata,George W Carnell,Hannah K Jackson,Jin S Lee,Jonathan C Brown,Thomas Burgoyne,Jonathan L Heeney,Klaus Okkenhaug,Andrew E Firth,Andrew A Peden,James R Edgar

Nature 622:562-573 PubMed37673118

2023

Complete human day 14 post-implantation embryo models from naive ES cells.

Applications

Unspecified application

Species

Unspecified reactive species

Bernardo Oldak,Emilie Wildschutz,Vladyslav Bondarenko,Mehmet-Yunus Comar,Cheng Zhao,Alejandro Aguilera-Castrejon,Shadi Tarazi,Sergey Viukov,Thi Xuan Ai Pham,Shahd Ashouokhi,Dmitry Lokshtanov,Francesco Roncato,Eitan Ariel,Max Rose,Nir Livnat,Tom Shani,Carine Joubran,Roni Cohen,Yoseph Addadi,Muriel Chemla,Merav Kedmi,Hadas Keren-Shaul,Vincent Pasque,Sophie Petropoulos,Fredrik Lanner,Noa Novershtern,Jacob H Hanna

bioRxiv : the preprint server for biology : PubMed33442692

2022

Tetherin antagonism by SARS-CoV-2 enhances virus release: multiple mechanisms including ORF3a-mediated defective retrograde traffic.

Applications

Unspecified application

Species

Unspecified reactive species

Hazel Stewart,Roberta Palmulli,Kristoffer H Johansen,Naomi McGovern,Ola M Shehata,George W Carnell,Hannah K Jackson,Jin S Lee,Jonathan C Brown,Thomas Burgoyne,Jonathan L Heeney,Klaus Okkenhaug,Andrew E Firth,Andrew A Peden,James R Edgar

Cell stem cell 29:1346-1365.e10 PubMed36055191

2022

Modeling human extraembryonic mesoderm cells using naive pluripotent stem cells.

Applications

Unspecified application

Species

Unspecified reactive species

Thi Xuan Ai Pham,Amitesh Panda,Harunobu Kagawa,San Kit To,Cankat Ertekin,Grigorios Georgolopoulos,Sam S F A van Knippenberg,Ryan Nicolaas Allsop,Alexandre Bruneau,Jonathan Sai-Hong Chui,Lotte Vanheer,Adrian Janiszewski,Joel Chappell,Michael Oberhuemer,Raissa Songwa Tchinda,Irene Talon,Sherif Khodeer,Janet Rossant,Frederic Lluis,Laurent David,Nicolas Rivron,Bradley Philip Balaton,Vincent Pasque

Experimental and therapeutic medicine 22:1459 PubMed34737799

2021

Specificity protein 1-activated bone marrow stromal cell antigen 2 accelerates pancreatic cancer cell proliferation and migration.

Applications

Unspecified application

Species

Unspecified reactive species

Chun Lei,Yafeng Hou,Jiong Chen
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com